Adenosine A2b Receptor Antikörper (AA 251-300)
-
- Target Alle Adenosine A2b Receptor (ADORA2B) Antikörper anzeigen
- Adenosine A2b Receptor (ADORA2B)
-
Bindungsspezifität
- AA 251-300
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Adenosine A2b Receptor Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human ADORA2B
- Isotyp
- IgG
- Top Product
- Discover our top product ADORA2B Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- Adenosine A2b Receptor (ADORA2B)
- Andere Bezeichnung
- ADORA2B (ADORA2B Produkte)
- Synonyme
- si:dkey-13b16.1 antikoerper, ADORA2B antikoerper, LOC606745 antikoerper, LOC100220469 antikoerper, ADORA2 antikoerper, A2BAR antikoerper, A2BR antikoerper, A2b antikoerper, AA2BR antikoerper, AI480866 antikoerper, AI605384 antikoerper, adenosine A2b receptor antikoerper, adenosine A2B receptor antikoerper, adora2b antikoerper, ADORA2B antikoerper, Adora2b antikoerper
- Hintergrund
-
Synonyms: ADORA2, Adenosine receptor A2b, ADORA2B
Background: Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.
- Gen-ID
- 136
- UniProt
- P29275
- Pathways
- cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-